ArticleActa Cardiologica Sinica2017
The Value of CHA
Article in Acta Cardiologica Sinica, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed.
- CHA2DS2-VA Score Can Be Used to Predict In-Hospital Mortality in Patients with Acute Aortic Dissection.Brazilian journal of cardiovascular surgery · 2026Article
- CHAFrontiers in cardiovascular medicine · 2025Article
- The value of PRECISE-DAPT score and lesion complexity for predicting all-cause mortality in patients with NSTEMI.The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology · 2023Article
- Four-factor prothrombin complex concentrate use for on-label versus off-label indications: a retrospective cohort study.Journal of thrombosis and thrombolysis · 2023Article
- The CHADiagnostics (Basel, Switzerland) · 2022Article
- Association of CHAHerz · 2022Article
- Atherosclerotic Burden is the Highway to Cardiovascular Events.Arquivos brasileiros de cardiologia · 2022Article
- Incidence of atrial fibrillation and its effects on long-term follow-up outcomes in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction.Anatolian journal of cardiology · 2021Article
- CHADS-VASc Score in STEMI Patients: Should We Use It Really?Acta Cardiologica Sinica · 2019Article
- In-Hospital Implementation of Evidence-Based Medications is Associated with Improved Survival in Diabetic Patients with Acute Coronary Syndrome - Data from TSOC ACS-DM Registry.Acta Cardiologica Sinica · 2018Article
- The association between CHA2DS2-VASc score and erectile dysfunction: a cross-sectional study.International braz j urol : official journal of the Brazilian Society of UrologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAcute coronary syndrome is the most common cause of cardiac morbidity and death. Various scoring systems have been developed in order to identify patients who are at risk for adverse outcome and may benefit from more aggressive and effective therapies.
objectivesThis study was designed to evaluate the CHA
methodsWe evaluated 300 patients diagnosed with ST-elevation myocardial infarction who underwent p-PCI and calculated their CHA
resultsAll-cause mortality was 4% in Group 1, 8.5% in Group 2 and 27.1% in Group 3 respectively. Kaplan-Meier analysis showed that Group 3 (CHA
conclusionsCHA
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.